Contributor:

Gus Gazzard, MD, FRCOphth, Sarwat Salim, MD

LiGHT: Efficacy and Cost Effectiveness

Gus Gazzard, MD, FRCOphth, Sarwat Salim, MD

Hydrus Microstent: Trimodal MoA

Gus Gazzard, MA(Cantab), MD, MBBChir, FRCOphth

SLT as First-Line Therapy

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Gus Gazzard, MA(Cantab), MD, MBBChir, FRCOphth

SLT as First-Line Therapy for POAG & OH

Prof. Gus Gazzard

Visual Field Progression in the LiGHT Trial

Gus Gazzard, MA(Cantab), MD, MBBChir, FRCOphth

Glaucoma Laser Assisted Solutions: Toward a Dropless Future

Prof. Gus Gazzard; Prof. Florent Aptel; Prof. Mark Latina

New Trends in the Treatment of PCO, Glaucoma, and Dry Eye

Prof. Mario de La Torre; Dr. Anas-Alexis Benyoussef; Prof. Gus Gazzard; Prof. Pablo Dighiero

New Trends in the Treatment of PCO, Glaucoma, and Dry Eye

Dr. Anas-Alexis Benyoussef; Prof. Gus Gazzard; Prof. Pablo Dighiero; and Prof. Mario de La Torre